Community News

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #earnings--Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. “I am proud of the progress we made in the second quarter. As we ramp towards commercial production, we have reached many of the milestones that we’ve been working towards and expect to reach many more in […]

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO Visian® Implantable Collamer® Lenses (EVO). EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia and astigmatism. Joe Jonas had myopia since childhood, which […]

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the second quarter of 2022. Second Quarter 2022 and Recent Highlights Total net sales were $16.7 million, with $14.5 million from Tru Niagen®, down 5% and 6% from the prior year period, respectively. Total net sales and Tru Niagen® net sales remained relatively flat year over year excluding the initial shelf stocking sales to Wal-Mart in the second quarter of 2021. Sales were […]

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 1, 2022. Second Quarter 2022 Overview Record Net Sales of $81.1 Million Up 30% and Constant Currency Net Sales of $84.2 Million Up 35% from the Prior Year Quarter Record ICL Sales of $77.9 Million Up 32% and Constant Currency ICL Sales of $80

PALM DESERT, Calif.--(BUSINESS WIRE)--Amputee Coalition 2022 National Conference comes to Palm Desert at the JW Marriott Desert Springs Resort & Spa welcoming over 650 attendees. Paralympic Silver Medal Combat Veteran and Amputee, John Register has been appointed Interim President and CEO of the Amputee Coalition. John Register will lead the organization to convene its 2022 National Conference (August 10-13) and Youth Camp, strengthen staff capacity, and deepen relationships with community

IRVINE, Calif.--(BUSINESS WIRE)-- #biogennix--Biogennix has reported that Q2 of 2022 was its record quarter for sales.

LOS ANGELES--(BUSINESS WIRE)--Scientists at City of Hope may have developed a novel blood test that can be used to detect early-onset colorectal cancer, a rising concern.

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the formation of a scientific advisory board (SAB) gathering world-renowned experts across several key disciplines in biomedical science and technology, including spectroscopy, diabetes technology, hydration science, and cardiology. The newly formed SAB will support Rockley’s […]

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the second quarter of 2022, ended July 2, 2022. Second Quarter 2022 Financial Results Consolidated revenue was $565.3 million, representing 85.3% reported growth compared to $305.1 million in the second quarter of 2021. Healthcare revenue was $357.0 million, which represents 17.0% reported growth and 19.0% constant currency growth on a constant currency basis. Non-healthcare revenue was $208.3 milli

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, welcomes Mr. Cary J. Claiborne to the CytRx Board of Directors (the “Board"). Mr. Claiborne brings to CytRx a wealth of experience in public company governance, finance and operational management. Mr. Claiborne is the Chief Operating Officer at Adial Pharmaceuticals, Inc. (“Adial”), a public […]

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #boardofdirectors--Rockley Photonics Names Richard Kuntz, M.D., to Board of Directors

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today called for entries for the seventh annual Life Science Catalyst Awards from the San Francisco Bay Area, San Diego and Los Angeles regions. The awards celebrate accomplished and up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers who are making their mark on the California life science […]

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on August 3, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 37,250 shares of Puma common stock to six new non-executive employees. The awards were granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity […]

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the closing of its public offering of 2,012,500 shares of its common stock at a price of $63.85 per share to the underwriter, which includes the exercise in full by the underwriter of its option to purchase 262,500 additional shares. The gross proceeds from the […]

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the direct-to-consumer healthcare apparel and lifestyle brand, today released its second quarter 2022 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Second Quarter 2022 Financial Highlights Net revenues were $122.2 million, an increase of 20.9% year over year, driven by an increase in orders as a result of […]

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent”, or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced financial results for its second quarter ended June 30, 2022. Second Quarter 2022 Results: Revenue of $125.3 million, versus $153.6 million in Q2 2021 Billable tests delivered over 1.3 […]

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will release its earnings results for 2Q-2022 and host a conference call to discuss results on Aug. 4, 2022.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today a new collaboration to enhance ADMET Predictor, its preeminent property prediction platform for drug discovery.

IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives with innovative interventional treatments for vascular disease, announced that is has received CE Mark Certification under the new EU Medical Devices Regulation [EU-MDR [(Regulation (EU) 2017/745)] for its AFX2 Endovascular AAA System. The EU-MDR is a regulation for medical devices applied by the European Commission, released in 2017 and effective as of May 26, […]

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of two therapeutic industry veterans to its board of directors. Dr. Michael Nohaile, Chief Scientific Officer of Generate Biomedicines (“Generate”), and Dr. Leonard Post, Chief Scientific Officer of Vivace Therapeutics (“Vivace”), who joined the company’s Board of Directors, effective August 1, 2022. “We are […]